Xeris Pharmaceuticals Inc reported $7.84M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acelrx Pharmaceuticals ACRX:US $ 1.42M 2.02M
Eli Lilly And LLY:US $ 5342M 555.1M
Endo International Ordinary Shares ENDP:US $ 474.91M 74.51M
Horizon Pharma HZNP:US $ 785.35M 153.8M
JAZZ PHA JAZZ:US $ 692.89M 60.27M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Perrigo Ordinary Shares PRGO:US $ 336.4M 12.6M
Supernus Pharmaceuticals SUPN:US $ 130.38M 14.08M
Teva Pharmaceutical Industries TEVA:US $ 1898M 25M
Zogenix ZGNX:US $ 21.32M 3.75M